Miris

What Miris does

Miris AB is a Swedish medical device company headquartered in Uppsala that develops, manufactures, and sells the Miris HMA (Human Milk Analyzer), a mid-infrared transmission spectroscopy instrument designed to quantitatively measure fat, carbohydrate, protein, total solids, and energy content in human milk. The device requires only a 3 ml sample and produces results in approximately 60 seconds, serving Neonatal Intensive Care Units (NICUs), human milk banks, and researchers focused on individualized nutrition for preterm infants through "target fortification." The HMA is registered as an in vitro diagnostic medical device in Europe, FDA-cleared in the United States (December 2018), and registered as a medical device in Japan.

The company's product portfolio is structured as an integrated ecosystem: the core HMA instrument is bundled with the Miris Ultrasonic Processor (which uses cavitation at approximately 20 J/s per ml to homogenize milk samples for accurate measurement) and the Miris Heater (a water-free warming system using bead-based heat). Complementing the hardware, Miris Forte is decision-support software that converts HMA macronutrient readings into tailored fortification recommendations for neonates (cloud and on-premise variants, developed per IEC 62304:2015 and ISO 13485:2016), while MyMiris is a web-based instrument management and user certification platform offered without additional charge. Recurring revenue is generated from consumables including the Miris Calibration Control Kit, Miris Check, Miris Cleaner, tubes (5 ml, 10 ml), and syringes (2 ml, 5 ml).

Miris commercializes through direct quote-based sales via its website, regional distribution partners (most recently Almazar Medical Corp covering Saudi Arabia, Bahrain, and UAE as of December 2025), the Miris Studio platform for live demonstrations and remote training, and participation in nine major neonatal and milk banking industry conferences. The HMA, Ultrasonic Processor, and Heater bundle is sold in more than 54 countries across all continents. The operating subsidiary Miris AB is wholly owned by Miris Holding AB, which has been listed on Sweden's Spotlight Stock Market under ticker MIR since June 22, 2006.

Name

Miris

Legal name

Miris AB

Website

https://mirissolutions.com

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Miris AB is a Swedish medical device company that develops and sells the Miris HMA, a mid-infrared spectroscopy instrument used by NICUs, milk banks, and researchers to measure macronutrients in human milk for individualized nutrition of preterm infants in 54+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Uppsala

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Human Milk Analyzer Equipment Sales: Sale of the Miris HMA instrument along with complete setup including Miris Ultrasonic Processor and Miris Heater. This is a capital equipment purchase for hospitals and milk banks.
2. Consumables: Recurring sales of consumables including Miris Calibration Control Kit, Miris Check, Miris Cleaner, tubes (5ml, 10ml), and syringes (2ml, 5ml).
3. Miris Forte Software: Decision support software for nutrition calculation and growth follow-up in neonatal care. Available as cloud-based and local server versions.
4. Miris Studio Services: Live online demonstrations, training sessions, and troubleshooting support for customers.
5. MyMiris Platform: Web-based instrument management system included free with target fortification products for handling instruments, user training/certification, and support contact.

Pricing tiers

Go-to-market motion4 records

Distribution channels3 records

Marketing channels10 records

Core offering

Miris develops, produces, and sells the Miris Human Milk Analyzer (HMA), a mid-infrared transmission spectroscopy medical device that quantitatively measures fat, protein, carbohydrate, total solids, and energy content in 3ml human milk samples within 60 seconds. The company offers a complete ecosystem including sample preparation equipment (Miris Ultrasonic Processor, Miris Heater), decision support software (Miris Forte), instrument management platform (MyMiris), and recurring consumables (Calibration Control Kit, Check, Cleaner, tubes, syringes). Products are sold to Neonatal Intensive Care Units (NICUs), human milk banks, and clinical researchers for target fortification of preterm infant nutrition.

Product overview

Miris offers a unified product ecosystem centered on human milk analysis for neonatal nutrition. The core product is the Miris Human Milk Analyzer (HMA), which uses mid-infrared spectroscopy to measure macronutrients in breast milk. This is complemented by the Miris Ultrasonic Processor for sample homogenization and Miris Heater for temperature preparation. Miris Forte software integrates with HMA data to calculate optimal fortification levels, while MyMiris provides web-based instrument management and user certification. The portfolio includes calibration consumables (Calibration Control Kit, Check, Cleaner), sample tubes, syringes, and a dedicated printer. The company operates in 54 countries with medical device registrations in Europe, Japan, and USA.

Differentiator

Problem solved

Functional benefit

Brands

• Miris HMA: Human Milk Analyzer - a medical device for macronutrient analysis of human milk measuring energy, fat, carbohydrate, and protein content.
• Miris Forte
• MyMiris
• Miris Studio
• Miris Ultrasonic Processor
• Miris Heater

Products and services

• Miris Human Milk Analyzer (HMA) Mid-infrared transmission spectroscopy instrument that quantitatively measures fat, carbohydrate, protein, total solids, and energy content in human milk samples within 60 seconds using a 3 ml sample volume. Registered as an in vitro diagnostic medical device in Europe, Japan, and USA.
• Miris Ultrasonic Processor High-intensity ultrasonic liquid processor that homogenizes milk samples using cavitation phenomenon, disrupting fat globules and stabilizing emulsions for accurate macronutrient analysis. Energy output approximately 20 J/s per ml of milk.
• Miris Heater Water-free warming system using beads as heat source to warm milk and solutions to 40°C for optimal analysis temperature, avoiding water contamination risk in samples.
• Miris Forte Decision support software for the calculation and follow-up of nutrition and growth in children under neonatal care. Integrates with Miris HMA analysis data to calculate fortification levels needed to meet infant nutritional goals. Available as cloud-based and local server versions. Developed per IEC 62304:2015 and ISO 13485:2016.
• MyMiris Web-based management system for handling Miris instruments, user training and certification, and support contact. Provides instrument overview, user certification tracking, and automated certificate expiration reminders. Offered free of charge to customers.
• Miris Calibration Control Kit Consists of two standardized solutions (Miris Calibration Control 1 and Miris Calibration Control 2) with known concentrations of fat, protein, and carbohydrates for daily validation of HMA internal calibration. CE marked.
• Miris Check Solution used to zero-set the analyzer and verify cleaning completion.
• Miris Cleaner Cleaning solution for the Human Milk Analyzer cuvette and instrument surface.
• Miris Printer Printer that automatically prints analysis results from the Human Milk Analyzer display.
• Miris Tubes (5ml and 10ml) 5ml and 10ml tubes for use with Miris Ultrasonic Processor tube holder, usable throughout milk analysis process including storage, warming, and homogenization.
• Miris Syringes (2ml and 5ml) 2ml and 5ml syringes for injecting milk samples and solutions into the Miris HMA.

Quantifiable outcome

• Two-week reduction in length of stay at Nürnberg Hospital NICU with target fortification
• +3 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Almazar Medical CorpcoreChannel Partner/ Reseller/ Distributor · 19 December 2025Distribution agreement covering Saudi Arabia, Bahrain, and UAE to expand Miris presence in the Middle East market. The deal supports Miris's goal to improve neonatal nutrition and leverages Almazar's regional expertise. The Middle East medical technology market is valued at approximately 11 billion USD.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Others

• Bio-Rad Laboratories: Bio-Rad manufactures life-science and clinical-diagnostic instruments and quality controls; it competes in the broader lab-instrument universe where Miris operates and supplies comparable channels of hospital procurement.
• Medela: Medela is the leading breast pump, milk expression, and lactation solutions supplier serving NICU workflows globally — an adjacent ecosystem participant that shares Miris's customer relationships and neonatal care sales channels even though it doesn't compete head-on in milk analysis.
• Revvity (formerly PerkinElmer): Revvity offers clinical diagnostics and life-science instrumentation including newborn screening and analytical platforms — an adjacent instruments supplier with overlapping hospital lab and clinical-research channels relevant to Miris's footprint.

Broad incumbents

• Beckman Coulter (Danaher): Beckman Coulter is a major clinical-chemistry and IVD vendor inside Danaher; its installed analyzers and consumables economics in hospital core labs overlap with the same procurement budgets Miris competes for at NICUs and milk banks.
• Roche Diagnostics: Roche is a global diagnostics incumbent with broad clinical-chemistry and IVD platforms that could in principle be extended to NICU milk-analysis workflows, representing a large-scale competitive threat to Miris.
• Siemens Healthineers: Siemens Healthineers runs the Atellica and ADVIA Centaur clinical-chemistry and immunoassay franchises inside hospital labs — adjacent IVD capabilities and a global salesforce that overlap with Miris's hospital procurement channels.
• FOSS Analytical: FOSS is a global leader in analytical instruments for dairy and food testing (MilkoScan family) and has overlapping mid-IR technology that could be repointed at human milk — a broad incumbent with the scale Miris lacks.
• Bentley Instruments: Bentley Instruments supplies infrared milk analyzers primarily to the dairy industry; comparable technology and channel, but not specifically optimized for human milk analysis or NICU workflows.
• Abbott Diagnostics: Abbott operates a global diagnostics business spanning clinical chemistry, immunoassays, and point-of-care; its installed hospital base and R&D budget overshadow Miris and could be redirected into specialized neonatal nutrition applications.

Direct peers

• Delta Instruments: Delta Instruments is a Dutch manufacturer of mid-IR milk analyzers, including the Calista model targeted at human milk analysis — the most directly comparable product competing against Miris HMA in NICU and milk bank workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/mirissolutions
• YouTubeyoutube.com/channel/UCby83a9ylEbdwK6ecNNZDtQ
• Facebookfacebook.com/mirissolutions
• LinkedInlinkedin.com/company/mirissolutions
• Instagraminstagram.com/mirissolutions

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miris